Research and Markets (http://www.researchandmarkets.com/research/vm7t89/cardiovascular)
has announced the addition of the "Cardiovascular
Diseases Therapeutics in Major Developed Markets to 2019 - Increasing
Prevalence and Promising Novel Drugs offset Patent Cliff Threat"
report to their offering.
The global market for Cardiovascular Disease (CVD) - comprising Heart
Failure (HF), Myocardial Infarction and Acute Coronary Syndrome (ACS) -
has registered modest growth from 2007-2012 due to the launch of various
blockbuster drugs. The market is expected to continue to grow at a
moderate rate over the 2012-2019 forecast period, due to the patent
expiry of a number of blockbuster drugs, including Lipitor
(atorvastatin) and Plavix (clopidogrel).
The value of the CVD market in the US is the highest of the countries
covered in thi report, amounting to an estimated $6.1 billion in 2012
and is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.7%
over the forecast period to reach $8.49 billion in 2019. The market for
all geographies (US, UK, Germany, France, Spain, Italy, Canada and
Japan) totaled $13.7 billion in 2012 and is expected to grow at a CAGR
of 4.1% to reach $18.2 billion in 2019.
Europe and North America are the Favorable Regions for Co-development
Deals in the Cardiovascular Market
Of the countries covered in this report, those of Europe and North
America countries were preferred by pharmaceutical players for the
purposes of conducting co-development deals in the cardiovascular market
during the 2007-2013 period. The vast majority of these deals - around
81% - took place exclusively in this region during this period.
The fiscal year ended 2009 accounted for the highest share of
co-development deals in terms of volume, with a total of $8 billion,
equivalent to around 64% of the total value of all co-development deals
for all three cardiovascular indications.
Key Topics Covered:
1.1 List of Tables
1.2 List of Figures
3 Therapeutic Landscape
4 Marketed Products
5 Pipeline Analysis
6 Cardiovascular Diseases Global Market to 2019, Market Forecast
7 Deals and Strategic Consolidations
List of Tables
List of Figures
For more information visit http://www.researchandmarkets.com/research/vm7t89/cardiovascular
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To NFVZone's Homepage ]